Founded in July 1999, Enzychem Lifesciences is a leader in the field of global new drug development, with a Global New Drug R&D center located in KAIST in Daejeon and two GMP manufacturing plants in Seoul. The company's products include veterinary medicine tablets, capsules, syrups, injections, ointments, and solutions for the diagnosis and prevention of various diseases. Enzychem Lifesciences Corp is also developing drugs to treat chemotherapy-induced neutropenia, chemo-radiation therapy-induced oral mucositis, asthma, psoriasis, rheumatoid arthritis, and others.